Join us to learn why genomic characterization of cohorts is essential for advancing precision medicine.
Large-scale population and disease-specific cohorts are transforming our understanding of human health and disease. In this webinar, Illumina will explore how genomic and multi-omic characterization enables deeper insight into common and complex diseases, supports preventive medicine, and accelerates the shift from reactive to proactive healthcare.
You will discover how insights from genotyping, sequencing, and multi-omic approaches can be combined to create a comprehensive view of your samples and the underlying biological mechanisms. We will also highlight the data analysis tools that help you extract maximum value from cohort-scale genomic data.
Whether you are building, expanding, or analyzing a cohort or biobank, this webinar will provide practical guidance and real-world examples to support your research.
Agenda

Stef Kupers
Segment Manager - Biobanks & Applied Markets
Illumina
M-EMEA-02204
Your email address is never shared with third parties.